couchtrader why hold then when all you contribute is negative 1 liners
you don't think a lousy $200k of sellers will get soaked up on becoming cash flow positive as a result of signing distribution deal ?
ALT had 20M+ volume days on the back of research alone
depth is of little significance to long term holders who are here for the signing of international distribution in Brazil and licensing in the US
Whether it is 2c or 10c, the market will value the deal accordingly when it happens, and that is very easy to do. The depth will make no difference
$3M p.a with free cash flow of $1.8M makes them a $20M company all day long or 4-5c. License deal in US and bank on double digits
A few lemming sellers are of no concern. If the company had no cash or trials then worry about depth. But with no dilution planned, $1M +, Brazil trials expanding and draft distribution agreement received, SE Asia meetings happening next month ...
What are you complaining about ? A few sellers ?
- Forums
- ASX - By Stock
- ALT
- quarterly
quarterly, page-13
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online